Speaker illustration

Doctor Carlos Escobar Cervantes

University Hospital La Paz, Madrid (Spain)

Member of:

Heart Failure Association

MD graduate at the Universidad Autonoma de Madrid. PhD grade at the Universidad de Alcalá; Doctoral Thesis qualification: A cum laude, unanimously. Specialist in Cardiology. Consultant cardiologist at Hospital La Paz (Madrid). Past President of the Clinical Cardiology group of the Spanish Society of Cardiology. Past-member of the Executive Committee of the Castilian Society of Cardiology. Member of the European Society of Cardiology (ESC). Member of the Cardiovascular Pharmacology and Drug Therapy Working Group of ESC. Referee of several national and international peer-review journals. Participation in several clinical trials and investigation projects in the fields of hypertension, heart failure, atrial fibrillation, acute coronary syndrome, and cardiometabolic disease. Over 250 papers published in national and international peer-review journals and over 40 chapters in Cardiology textbooks.

Stroke and bleed related deaths in newly diagnosed atrial fibrillation patients: insights from the GARFIELD-AF registry

Event: ESC Congress 2022

Topic: Cardiogenic Embolism

Session: Peripheral arterial and cerebrovascular disease 2


Potential low-density lipoprotein cholesterol, cardiovascular risk and costs reduction with evolocumab: a simulation in patients with a recent myocardial infarction in Spain

Event: ESC Congress 2021 - The Digital Experience

Topic: Drug therapy

Session: Risk Factors and Prevention ePosters


Resource utilization and costs associated with achieved LDL-C levels in patients following a myocardial infarction treated with lipid-lowering therapies in Spain

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Health Economics

Session: Public Health and Health Economics ePosters


Pulmonary vein isolation by high-power short-duration radiofrequency applications: short term efficacy and safety in patients with atrial fibrillation

Event: EHRA 2019

Topic: Rhythm Control, Catheter Ablation

Session: Best graded abstracts


Anticoagulation and CHA2DS2-VASc score of 1 - CONTRA

Event: EHRA 2019

Topic: Treatment

Session: Knowledge gaps in clinical atrial fibrillation


This platform is supported by

logo Novo Nordisk